DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b558ed/global_protein_the) has announced the addition of the "Global Protein Therapeutics Market Analysis" report to their offering.
Within the global pharmaceutical industry, protein therapeutics has been enjoying the fastest growth for the past few years. Playing a significant role in the treatment of many major diseases, protein therapies have revolutionized the methodology followed by drugs. These therapies owe their high efficiency to their targeted approach, which avoids side effects on healthy organs to a great extent. The acceptance of the various protein therapies can be attributed to the increasing prevalence of chronic diseases, such as cancer, diabetes, cardiovascular diseases, and rising penetration of medical insurance.
According to this new research report Global Protein Therapeutics Market Analysis, the global protein therapeutics market is expected to grow at a CAGR of around 13% during 2012-2014. Various factors, such as introduction of new protein therapeutics and enhanced investments will contribute to the buoyant growth of this industry. Besides, augmentation in the number of clinical trials will surface the optimistic performance of the industry.
Based on this in-depth analysis of the industry, the authors have identified the major segments in protein therapeutics market, which include Monoclonal antibody, Insulin, Interferon, G-CSF, coagulation factors etc. Amongst the segments, monoclonal antibody dominates the global protein therapeutics market and is expected to be at the top in future as well. This has been possible due to the large numbers of players that have been directing their efforts to develop innovative treatments using mAbs.
As per this research, fast growth in protein therapeutics will also strengthen other emerging sectors. Bio-generics will represent a key future growth segment as it will try to offset the loss of market revenue as a result of patent expirations of branded therapies. Additionally, the market trends studied in the report suggest that, a lot of research work in the segment would be targeting the immunogenicity issues related to the protein therapies.
The report provides extensive information and rational analysis of the global protein therapeutics market. It has thoroughly examined current market trends, industrial developments, and competitive landscape to enable clients understands the market structure and its progress in coming years. The forecasts presented in the report are based on the correlation between the market trends and drivers.
Key Topics Covered:
1. Analyst View
2. Global Protein Therapeutics Market
2.1 Market Analysis
2.2 Future Outlook (2012-2014)
3. Industry Performance
3.1 Monoclonal Antibodies (mAbs)
3.2 Erythropoietin (EPO)
3.3 Insulin
3.4 Interferon (IFN)
3.5 Human Growth Hormone (HGH)
3.6 Blood Clotting Factor
3.7 Follicle Stimulating Hormone (FSH)
3.8 Granulocyte Colony Stimulating Factor (G-CSF)
4. Emerging Market Trends
4.1 Synthetic Biology: Taking Command of the Industry
4.2 Drug-like Protein Therapies: Increasing Stability
4.3 Effective Delivery Methods: Improving the Reach of Therapies
4.4 Tackling Immunogenicity Issues: Ensuring Product Safety
4.5 Multifunctional Proteins: Targeting Wider Range of Diseases
5. Key Players
5.1 Johnson & Johnson
5.2 Biogen Idec Inc.
5.3 Eli Lilly & Company
5.4 Sanofi-Aventis
5.5 Merck Serono S.A.
5.6 Roche Group
5.7 Amgen Inc.
For more information visit http://www.researchandmarkets.com/research/b558ed/global_protein_the.